Skip to main content
MOA Life Plus Co. Ltd. logo

MOA Life Plus Co. Ltd. — Investor Relations & Filings

Ticker · 142760 ISIN · KR7142760008 KO Manufacturing
Open in API
Filings indexed 361 across all filing types
Latest filing 2023-03-16 AGM Information
Country KR South Korea
Listing KO 142760

About MOA Life Plus Co. Ltd.

http://moalifeplus.com/

MOA Life Plus Co. Ltd. is a biopharmaceutical company that researches and develops innovative medicines and consumer healthcare products. The company's pharmaceutical division focuses on a pipeline of biopharmaceuticals, including immunotherapies, cancer treatments, and vaccines for infectious diseases. A core platform technology utilizes Gamma-Polyglutamic Acid (γ-PGA), a natural amino acid polymer derived from fermented foods, to enhance immune responses and serve as a vaccine adjuvant. The consumer business division provides tailored healthcare solutions for immunity enhancement, skin rejuvenation, and pet care. It also manufactures and supplies γ-PGA-based raw materials for the cosmetics industry.

Recent filings

Filing Released Lang Actions
주주총회소집공고
AGM Information Classification · 100% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for BioLeaders (주식회사 비엘). It contains the agenda for the 23rd Annual General Meeting, including reports on financial statements, board appointments, and remuneration limits. It also includes detailed financial statements (balance sheets, income statements, and statements of changes in equity) as part of the meeting materials provided to shareholders. This type of document is classified as AGM Information (AGM-R) as it contains the materials and agenda for the meeting.
2023-03-16 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Proxy Solicitation Reference Document) and contains information regarding the upcoming Annual General Meeting (AGM) of the company 'BL'. It includes details on the meeting agenda, voting procedures (electronic voting/proxy), and financial statements (balance sheet, income statement, etc.) for the purpose of shareholder review prior to the meeting. This is a standard proxy solicitation document used to request shareholder votes for an AGM.
2023-03-15 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Proxy Solicitation Reference Document) and contains information regarding the solicitation of proxies for a general meeting of shareholders, including the meeting date, agenda items, and voting procedures. This aligns perfectly with the definition of a Proxy Solicitation & Information Statement (PSI).
2023-03-10 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의). It outlines the date, location, and agenda items (such as financial statement approval, director appointments, and remuneration limits) for the upcoming Annual General Meeting. This type of document is a standard proxy solicitation/information statement provided to shareholders to inform them of the meeting and request their participation/votes.
2023-03-09 Korean
주주총회집중일개최사유신고
AGM Information Classification · 98% confidence The document is a formal regulatory filing submitted by the company (주)비엘 regarding the scheduling of its Annual General Meeting (AGM) on a 'concentrated date' (a date when many companies hold their AGMs). It explains the reasons for choosing this date and provides the meeting date and notice date. Since it is a regulatory disclosure regarding meeting logistics rather than the AGM presentation materials themselves, and it does not fit into specific categories like proxy solicitation or voting results, it is classified as a general regulatory filing.
2023-03-09 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from a Korean company (BIEL) regarding the acquisition of convertible bonds before maturity (Call Option exercise). This type of filing relates to changes in capital structure and debt instruments. Among the provided categories, 'CAP' (Capital/Financing Update) is the most appropriate as it covers financing activities and changes to capital structure, including the repurchase or acquisition of debt securities.
2023-01-18 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.